comparemela.com

Latest Breaking News On - Pharmaceuticals stock down - Page 5 : comparemela.com

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Recommendation of "Moderate Buy" by Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]

Canada
Wellington
New-zealand-general
New-zealand
Amyw-schulman
William-blair
Capital-research-global-investors
Alnylam-pharmaceuticals-stock-down
News-ratings-for-alnylam-pharmaceuticals-daily
Norges-bank
Alnylam-pharmaceuticals
Institutional-trading-of-alnylam-pharmaceuticals

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Sees Significant Drop in Short Interest

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 800 shares, a decrease of 92.5% from the April 30th total of 10,700 shares. Based on an average trading volume of 16,600 shares, […]

Armata-pharmaceuticals-company-profile
Seacrest-wealth-management
Armata-pharmaceuticals-inc
News-ratings-for-armata-pharmaceuticals-daily
Armata-pharmaceuticals
Hedge-funds-weigh-in-on-armata-pharmaceuticals
Armata-pharmaceuticals-stock-down
Get-free-report
Crest-wealth-management
Free-report
Pharmaceuticals-stock-down

TD Asset Management Inc Sells 29,279 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

TD Asset Management Inc Sells 29,279 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Royal-bank
Td-asset-management-inc
Quarter-for-alnylam-pharmaceuticals
Alnylam-pharmaceuticals-stock-down
Exchange-commission
Alnylam-pharmaceuticals-inc
Alnylam-pharmaceuticals
Morgan-stanley
Oxford-asset-management
Nixon-peabody-trust-co

Provident Investment Management Inc. Sells 850 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Provident Investment Management Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 160,319 shares of the pharmaceutical company’s stock after selling 850 shares during the quarter. Vertex […]

Brucei-sachs
William-blair
News-ratings-for-vertex-pharmaceuticals-daily
Securities-exchange-commission
Vertex-pharmaceuticals-incorporated
Provident-investment-management-inc
Vertex-pharmaceuticals-stock-down
Exchange-commission
Quarter-for-vertex-pharmaceuticals
Vertex-pharmaceuticals-company-profile
Vertex-pharmaceuticals
Wolfe-research

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Sees Large Growth in Short Interest

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 600 shares, an increase of 500.0% from the April 30th total of 100 shares. Based on an average trading volume of 5,000 shares, […]

Switzerland
United-states
Australia
News-ratings-for-clinuvel-pharmaceuticals-daily
Clinuvel-pharmaceuticals-stock-down
Clinuvel-pharmaceuticals-limited
Clinuvel-pharmaceuticals
Get-free-report
Pharmaceuticals-stock-down
Pharmaceuticals-limited
Clinuvel-pharmaceuticals-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.